Status:
RECRUITING
Validation of Rapid On-site Diagnostics in Early Stage Lung Cancer Sampling With a Higher Harmonic Generation Microscope
Lead Sponsor:
Radboud University Medical Center
Collaborating Sponsors:
Flash Pathology BV
VU University of Amsterdam
Conditions:
Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The aim of this study is to verify a new microscopic technique in diagnosing patients suspected of lung cancer. Patients will undergo navigational bronchoscopy or surgical resection as a part of stand...
Detailed Description
The gold standard for diagnosing all suspected malignancies, such as lung cancer, involves pathological examination using light microscopy, supplemented with immunohistochemical techniques and molecul...
Eligibility Criteria
Inclusion
- ASA physical status 1-3.
- Age 18 years or older.
- A pulmonary lesion with an indication for diagnostic or therapeutic evaluation following current clinical guidelines and/or as decided by multi-disciplinary team consultation.
Exclusion
- Bleeding disorders.
- Less than 18 years old.
- Inability to consent.
- Unfit for navigation bronchoscopy and/or unfit for surgical resection as per guideline recommended care and multi-disciplinary tumor board decision making.
Key Trial Info
Start Date :
January 19 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 1 2027
Estimated Enrollment :
250 Patients enrolled
Trial Details
Trial ID
NCT06007261
Start Date
January 19 2024
End Date
April 1 2027
Last Update
January 24 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Radboudumc
Nijmegen, Gelderland, Netherlands, 6525GA